Evidence map›Paper›PMID 33512605›Full record

SynthesisJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2022

Complication rates following ventricular tachycardia ablation in ischaemic and non-ischaemic cardiomyopathies: a systematic review.

Wern Yew Ding, Charles M Pearman, Laura Bonnett, Ahmed Adlan, Shui Hao Chin, Nathan Denham, Simon Modi, Derick Todd, Mark C S Hall, Saagar Mahida

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Cryocure-VT: the safety and effectiveness of ultra-low-temperature cryoablation of monomorphic ventricular tachycardia in patients with ischaemic and non-ischaemic cardiomyopathies.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Trial
  3. Efficacy and safety of ventricular tachycardia ablation versus antiarrhythmics in ischemic cardiomyopathy: a network meta-analysis.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Characterization of ventricular tachycardia ablation in end-stage heart failure patients with left ventricular assist device (CHANNELED registry).Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Observational
  12. Observational
  13. Review
  14. Review
  15. Review
  16. Article
  17. Radiation therapy for ventricular arrhythmias.Journal of medical imaging and radiation oncology · 2024
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Wern Yew DingDepartment of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK. dwyew@hotmail.com.ORCID http://orcid.org/0000-0003-3596-6545
Charles M PearmanDepartment of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK.
Laura BonnettDepartment of Biostatistics, University of Liverpool, Liverpool, UK.
Ahmed AdlanDepartment of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK.
Shui Hao ChinDepartment of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK.
Nathan DenhamUnit of Cardiac Physiology, Institute of Cardiovascular Sciences, Manchester Academic Health Sciences Centre, The University of Manchester, Manchester, UK.
Simon ModiDepartment of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK.
Derick ToddDepartment of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK.
Mark C S HallDepartment of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK.
Saagar MahidaDepartment of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK.
University of Liverpool · GBManchester Academic Health Science Centre · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCatheter ablation of ventricular tachycardia (VT) is associated with potential major complications, including mortality. The risk of acute complications in patients with ischaemic cardiomyopathy (ICM) and non-ischaemic cardiomyopathy (NICM) has not been systematically evaluated.

methodsPubMed was searched for studies of catheter ablation of VT published between September 2009 and September 2019. Pre-specified primary outcomes were (1) rate of major acute complications, including death, and (2) mortality rate.

resultsA total of 7395 references were evaluated for relevance. From this, 50 studies with a total of 3833 patients undergoing 4319 VT ablation procedures fulfilled the inclusion criteria (mean age 59 years; male 82%; 2363 [62%] ICM; 1470 [38%] NICM). The overall major complication rate in ICM cohorts was 9.4% (95% CI, 8.1-10.7) and NICM cohorts was 7.1% (95% CI, 6.0-8.3). Reported complication rates were highly variable between studies (ICM I

conclusionOverall acute complication rates of VT ablation are comparable between ICM and NICM patients. However, the pattern and predictors of complications vary depending on the underlying cardiomyopathy.

Indexed as

CardiomyopathiesCatheter AblationMyocardial IschemiaTachycardia, VentricularHumansMaleMiddle AgedCatheter ablationComplicationsDeathIschaemic cardiomyopathyMortalityNon-ischaemic cardiomyopathyStructural heart diseaseVentricular tachycardia

Identifiers

PMID33512605
PMCPMC8755671
OpenAlexW3123255901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.